Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2025-12-24 @ 4:15 PM
Study NCT ID:
NCT03322566
Status:
COMPLETED
Last Update Posted:
2022-01-24
First Post:
2017-10-24
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)
Sponsor:
Incyte Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-16
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-24
First Submit QC Date:
None
Study First Post Date:
2017-10-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2019-12-10
Results First Submit QC Date:
None
Results First Post Date:
2020-01-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-19
Last Update Post Date:
2022-01-24
Last Update Post Date Type:
ACTUAL